Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -711 | N/A | N/A |
| Other Working Capital | -570 | N/A | N/A |
| Other Operating Activity | 604 | 0 | 0 |
| Operating Cash Flow | $-678 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Purchase Of Investment | -250,000 | N/A | N/A |
| Investing Cash Flow | $-250,000 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -178 | N/A | N/A |
| Common Stock Issued | 245,025 | N/A | N/A |
| Other Financing Activity | 7,166 | 0 | 0 |
| Financing Cash Flow | $252,013 | $N/A | $N/A |
| End Cash Position | 1,335 | N/A | N/A |
| Net Cash Flow | $1,335 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -678 | N/A | N/A |
| Free Cash Flow | -678 | 0 | 0 |